# Renke

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/renke

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Angel (Sep 22, 2022)
- Investors on record: 3

## About

Founded in 2021 and based in Beijing, China, Renke is a biotech company that develops genomics and tumor genetic testing technologies. Xun Lan, the founder of the company, has more than ten years of experience in multi-omics research and early cancer screening research.

The company's main products are pan-cancer early screening products. Its products cover from early screening of tumors, mid-stage diagnosis, to late-stage treatment and monitoring. Pan-cancer early screening products can detect cancers such as stomach and lung cancers.

## Funding rounds

- Angel, Sep 22, 2022 — Unity Ventures, Tsinghua Innovation Ventures, Tianjin Huakong Dianke Capital

## Investors

- Unity Ventures (https://capitalatlas.ai/funds/unity-ventures) — Angel
- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Angel
- Tianjin Huakong Dianke Capital (https://capitalatlas.ai/funds/tianjin-huakong-dianke-capital) — Angel